EGFR inhibitor enhances cisplatin sensitivity of oral squamous cell carcinoma cell lines

Pathology and Oncology Research

Volumn 14, Issue 1, 2008, Pages 39-43

  Hiraishi, Yukihiro ^a   Wada, Takeshi ^a   Nakatani, Ken ^a   Tojyo, Itaru ^a   Matsumoto, Takashi ^a   Kiga, Norifumi ^a   Negoro, Kenji ^a   Fujita, Shigeyuki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cisplatin sensitivity and resistance; Cisplatin resistant OSCC cell line; EGFR inhibitor; Epidermal growth factor receptor (EGFR); Oral squamous cell carcinoma (OSCC)

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR;

ARTICLE; CANCER CELL CULTURE; CELL CULTURE; CONTROLLED STUDY; DRUG INHIBITION; DRUG SENSITIVITY; HUMAN; HUMAN CELL; MOUTH CARCINOMA; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CISPLATIN; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INHIBITORS; HUMANS; MOUTH NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TYRPHOSTINS;

EID: 49349089206     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-008-9020-5     Document Type: Article

References (26)

1. DS Salomon R Brandt F Ciardiello 1995 Epidermal growth factor-related peptides and their receptors in human malignancies Crit Rev Oncol Hematol 19 183 232
2. Y Hiraishi T Wada K Nakatani 2006 Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas Pathol Oncol Res 12 87 91
3. SM Huang PM Harari 1999 Epidermal growth factor receptor inhibition in cancer therapy: Biology, rationale and preliminary clinical results Invest New Drugs 17 259 269
4. N Prenzel OM Fischer S Streit 2001 The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification Endocr Relat Cancer 8 11 31
5. JB Gibbs 2000 Anticancer drug targets: growth factors and growth factor signaling J Clin Invest 105 9 13
6. J Mendelsohn 2001 The epidermal growth factor receptor as a target of cancer therapy Endocr Relat Cancer 8 3 9
7. RS Herbst WK Hong 2002 IMC-C225, anti-epidermal growth factor receptor monoclonal antibody for treatment of head and neck cancer Semin Oncol 29 18 30
8. M Fukuoka S Yano G Giaccone 2003 Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer J Clin Oncol 21 2237 2246
9. J Mendelsohn J Baselga 2003 Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer J Clin Oncol 21 2787 2799
10. LB Saltz NJ Meropol PJ Loehrer 2004 Phase II trial of cetuximab in patients with refractory colorectal cancer that express the epidermal growth factor receptor J Clin Oncol 22 1201 1208
11. RD Christen DK Hom DC Porter 1990 Epidermal growth factor regulates the in vitrosensitivity of human ovarian carcinoma cells to cisplatin J Clin Invest 86 1632 1640
12. E Aboud-Pirak E Hurwitz ME Pirak 1988 Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice J Natl Cancer Inst 80 1605 1611
13. Q Dai YH Ling M Lia 2005 Enhanced sensitivity to the HER1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib hydrochloride in chemotherapy resistant tumor cell lines Clin Cancer Res 11 1572 1578
14. M Benhar D Engelberg A Levitzki 2002 Cisplatin-induced activation of the EGF receptor Oncogene 21 8723 8731
15. J Bourhis 2005 New approaches to enhance chemotherapy in SCCHN Ann Oncol 16 20 24
16. JK Chan H Pham XJ You 2005 Suppression of ovarian cancer cell tumorigenicity and evasion of Cisplatin resistance using a truncated epidermal growth factor receptor in a rat model Cancer Res 65 3243 3248
17. M Nakamura K Nakatani K Uzawa 2005 Establishment and characterization of a cisplatin-resistant oral squamous cell carcinoma cell line, H-1R Oncol Rep 14 1281 1286
18. K Nakatani M Nakamura K Uzawa 2005 Establishment and gene analysis of a cisplatin-resistant cell line, Sa-3R, derived from oral squamous cell carcinoma Oncol Rep 13 709 714
19. J Downward P Parker MD Waterfield 1984 Autophosphorylation sites on the epidermal growth factor receptor Nature 311 483 485
20. MA Olayioye RM Neve HA Lane 2000 The ErbB signaling network: receptor heterodimerization in development and cancer EMBO J 19 3159 3167
21. X Wang JL Martindale NJ Holbrook 2000 Requirement for ERK activation in cisplatin-induced apoptosis J Biol Chem 275 39435 39443
22. M Benhar I Dalyot D Engelberg 2001 Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress Mol Cell Biol 21 6913 6926
23. RG Deschesnes J Huot K Valerie 2001 Involvement of p38 in apoptosis-associated membrane blebbing and nuclear condensation Mol Biol Cell 12 1569 1582
24. Z Chen X Zhang M Li 2004 Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck Clin Cancer Res 10 5930 5939
25. A El-Marjou A Delouvee JP Thiery 2000 Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumor progression Carcinogenesis 21 2211 2218
26. AE Wakeling 2002 Epidermal growth factor receptor tyrosine kinase inhibitors Curr Opin Pharmacol 2 382 387